Updated

The Department of Health and Human Services will allow small compounding pharmacies to make six peptides that the Food and Drug Administration has not approved, under an enforcement discretion policy, on October 28, 2026. NPR Health reported the move may not be enough to meet demand. Ars Technica reported that RFK Jr. granted the access unilaterally, overruling the FDA, and that peptide sellers welcomed the decision.